1. Ifosfamide‐induced encephalopathy: Brand‐name (HOLOXAN®) vs generic formulation (IFOSFAMIDE EG®). (4th March 2019) Authors: Chambord, Jeremy; Henny, Fabien; Salleron, Julia; Hombourger, Benoit; Lider, Pauline; Vigneron, Jean; Demore, Beatrice; Vallance, Catherine; Rios, Maria Journal: Journal of clinical pharmacy and therapeutics Issue: Volume 44:Number 3(2019) Page Start: 372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pemetrexed stability: additional information about microparticles. Issue 1 (24th May 2018) Authors: D'Huart, Elise; Vigneron, Jean; Morice, Sophie; Lider, Pauline; Demoré, Béatrice Journal: European journal of hospital pharmacy Issue: Volume 26:Issue 1(2019) Page Start: 56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Physicochemical stability of etoposide diluted at range concentrations between 0.38 and 1.75 mg/mL in polyolefin bags. Issue 1 (7th July 2018) Authors: D'Huart, Elise; Vigneron, Jean; Lider, Pauline; Demoré, Béatrice Journal: European journal of hospital pharmacy Issue: Volume 27:Issue 1(2020) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Quality control of cytotoxic infusions disturbed by a change of infusion bag: A case report. Issue 2 (April 2019) Authors: Le Quinio, Pierre; Beiler, Benoît; Lider, Pauline; Demoré, Béatrice; Vigneron, Jean Journal: European journal of oncology pharmacy Issue: Volume 2:Issue 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗